Investigation of the Effects of Three Different Generations of Fluoroquinolone Derivatives on Erythrocyte Fragility and Hematological Parameters in Rats

Yıl 2023, , 237 - 243, 30.12.2023

Fatih Donmez , Abdulahad Doğan

https://doi.org/10.52976/vansaglik.1330882

Öz

Objektive: Fluoroquinolones (FQs) are synthetic broad-spectrum antimicrobial agents derived from nalidixic acid. They are used in the treatment of urinary tract infections, respiratory tract infections, skin infections, digestive system infections, genital infections and other bacterial infections. Although the relationship between FQs and oxidative stress has been demonstrated, their effects on erythrocyte fragility have not been adequately studied. In this study, the effects of three different FQ derivatives (ciprofloxacin (CIP), levofloxacin (LVX) and moxifloxacin (MXF)) on erythrocyte fragility and hematological parameters were investigated in rats at the end of the 1st, 7th and 14th day treatments.
Material and Method: 72 Wistar albino male rats were divided into 4 groups with 18 rats in each group and sacrificed at three different time points (1st, 7th and 14th days).
Results: A significant increase in 0.2% sodium chloride (NaCl) concentration erythrocyte fragility value was found in the MXF group on 1st day compared to the control group on 1st day. While the FQ derivatives used in the study did not cause a general change on the erythrocyte and leukocyte parameters, they caused various fluctuations on the platelet parameters such as PCT, PLCR, PDW, MPW and PLT.
Conclusion: As a further study, it would be beneficial to reveal the reasons for these effects on platelet parameters with more detailed studies.

Anahtar Kelimeler

Erythrocyte fragility, Hematological parameters, Levofloxacin, Moxifloxacin, Ciprofloxacin

Destekleyen Kurum

This study was financially supported by Van Yuzuncu Yil University, Scientific Research Project Commission.

Proje Numarası

Project Number (TYL-2020–8809).

Teşekkür

We thank the Van Yüzüncü Yıl University Scientific Research Projects Commission for supporting this study.

Üç Farklı Kuşak Florokinolon Türevinin Ratlarda Eritrosit Frajilite ve Hematolojik Parametreler Üzerindeki Etkilerinin Araştırılması

Öz

Amaç: Florokinolonlar (FQ'lar), nalidiksik asitten türetilen sentetik geniş spektrumlu antimikrobiyal ajanlardır. Bu grup idrar yolu enfeksiyonları, solunum yolu enfeksiyonları, deri enfeksiyonları, sindirim sistemi enfeksiyonları, genital enfeksiyonlar ve diğer bakteriyel enfeksiyonların tedavisinde kullanılırlar. FQ'ların oksidatif stres ile ilişkisi gösterilmiş olmasına rağmen, eritrosit frajilite üzerindeki etkileri yeterince araştırılmamıştır. Bu çalışmada üç farklı florokinolon türevinin (siprofloksasin (CIP), levofloksasin (LVX) ve moksifloksasin (MXF)) 1, 7 ve 14 günlük tedavilerinin eritrosit frajilite ve hematolojik parametreler üzerindeki etkileri araştırıldı.
Materyal ve Metod: 72 Wistar albino erkek ratlar her grupta 18 rat olacak şekilde 4 gruba ayrılarak üç farklı zaman noktasında (1., 7. ve 14. günler) sakrifiye edildiler.
Bulgular: % 0.2 sodyum klorür (NaCl) konsantrasyonu eritrosit frajilite değeri 1. gün MXF grubu 1. gün kontrol grubu ile karşılaştırıldığında anlamlı artış göstermiştir. Çalışmada kullanılan FQ türevleri eritrosit ve lökosit parametrelerinde genel bir değişikliğe neden olmazken PCT, PLCR, PDW, MPW ve PLT gibi trombosit parametrelerinde çeşitli dalgalanmalara neden olmuştur.
Sonuç: İleri bir çalışma olarak trombosit parametreleri üzerindeki bu etkilerin nedenlerinin daha detaylı çalışmalarla ortaya konması faydalı olacaktır.

Anahtar Kelimeler

Eritrosit frajilite, Hematolojik parametreler, Levofloksasin, Moksifloksasin, Siprofloksasin

Proje Numarası

Project Number (TYL-2020–8809).

Kaynakça

• Afolabi OK, Oyewo EB. (2014). Effects of ciprofloxacin and levofloxacin administration on some oxidative stress markers in the rat. International Journal of Biotechnology and Bioengineering, 8(1), 72-76.
• Akyol S, Mas MR, Comert B, Ateskan Ü, Yasar M, Aydogan H, et al. (2003). The effect of antibiotic and probiotic combination therapy on secondary pancreatic infections and oxidative stress parameters in experimental acute necrotizing pancreatitis. Pancreas, 26(4), 363-367.
• Baboldashti NZ, Poulsen RC, Franklin, SL, Thompson MS, Hulley PA. (2011). Platelet-rich plasma protects tenocytes from adverse side effects of dexamethasone and ciprofloxacin. The American Journal of Sports Medicine, 39(9), 1929-1935.
• Bertrand N, Leroux JC. (2012). The journey of a drug-carrier in the body: an anatomo-physiological perspective. Journal of Controlled Release, 161(2), 152-163.
• Colino CI, García Turiño A, Sanchez Navarro A, Lanao JM. (1998). A comparative study of ofloxacin and ciprofloxacin erythrocyte distribution. Biopharmaceutics and Drug Disposition, 19(2), 71-77.
• Doğan A, Dönmez F, Anuk ÖO. (2020). Evaluation of the erythrocyte fragility, haematological parameters and antioxidant properties of Platanus orientalis leaf infusion against ethanol toxicity in rats. Alinteri Journal of Agriculture Science, 35(1), 22-28.
• Donmez F, Dogan A. (2022). Investigation of the effects of three different generations of fluoroquinolone derivatives on antioxidant and immunotoxic enzyme levels in different rat tissues. Drug and Chemical Toxicology, 45(6), 2686-2698.
• Dönmez F, Yardım Y, Şentürk Z. (2018). Electroanalytical determination of enrofloxacin based on the enhancement effect of the anionic surfactant at anodically pretreated boron-doped diamond electrode. Diamond and Related Materials, 84, 95-102.
• Ezelarab HA, Abbas SH, Hassan HA, Abuo‐Rahma GEDA. (2018). Recent updates of fluoroquinolones as antibacterial agents. Archiv der Pharmazie, 351(9), 1-13.
• Gladysz MZ, Stevanoska M, Włodarczyk-Biegun MK, Nagelkerke A. (2022). Breaking through the barrier: Modelling and exploiting the physical microenvironment to enhance drug transport and efficacy. Advanced Drug Delivery Reviews, 184, 1-20.
• Hu YQ, Zhang S, Xu Z, Lv ZS, Liu ML, Feng LS. (2017). 4-Quinolone hybrids and their antibacterial activities. European Journal of Medicinal Chemistry, 141, 335-345.
• Huang L, Liu J, Yu X, Shi L, Liu J, Xiao H, et al. (2016). Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats. Biomedical Chromatography, 30(10), 1591-1598. Igbokwe NA. (2018). A review of the factors that influence erythrocyte osmotic fragility. Sokoto Journal of Veterinary Sciences, 16(4), 1-23.
• Kovalenko ІV, Оnufrovych ОK, Vorobets NM, Меlnyk ОV, Vorobets ZD. (2019). Аrginase/NO-synthase system сharacteristics in blood lymphocytes under effect of fluoroquinolones. Regulatory Mechanisms in Biosystems, 10(2), 203-208.
• Luqman S, Prabu KO, Pal A, Saikia D, Darokar MP, Khanuja SP. (2006). Antibiotic-induced alterations in the osmotic resistance of erythrocytes is modulated by β-carotene and L-ascorbic acid. Natural Product Communications, 1(6), 481-486.
• Maris AS, Mody P, Brewer DJ, Humphries RM. (2021). The Fluoroquinolones: An update for the clinical microbiologist. Clinical Microbiology Newsletter, 43(12), 97-107.
• Meinke M, Müller G, Helfmann J, Friebel M. (2007). Optical properties of platelets and blood plasma and their influence on the optical behavior of whole blood in the visible to near infrared wavelength range. Journal of Biomedical Optics, 12(1), 1-9.
• Rawi SM, Mourad IM, Arafa NM, Alazabi NI. (2011). Effect of ciprofloxacin and levofloxacin on some oxidative stress parameters in brain regions of male albino rats. African Journal of Pharmacy and Pharmacology, 5(16), 1888-1897.
• Stahlmann R, Lode H. (2010). Safety considerations of fluoroquinolones in the elderly: an update. Drugs and Aging, 27, 193-209.
• Surana SP, Sardinas Z, Multz AS. (2012). Moxifloxacin (avelox) induced thrombotic thrombocytopenic purpura. Case Reports in Medicine, 2012, 1-3.
• Xie R, Zheng W, Guan L, Ai Y, Liang Q. (2020). Engineering of hydrogel materials with perfusable microchannels for building vascularized tissues. Small, 16(15), 1-17.